KpATCC43816 Protein target profile

pyrimidine utilization protein D

Accession: VK055_1442

Gene: rutD AIK80063.1 3D evidence: AlphaFold DB model + ColabFold model Metabolism Not in network UniProt A0A377TPP8
Length 266
Pocket druggability (P2Rank · AlphaFold DB model) 0.939
Direct ligand evidence 0 55 total records
Functional annotation 1 EC 4 GO
Target summary

Promising target candidate with multiple supporting evidence streams.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
Hit
Human identity (%)
28.431 Lower values reduce human off-target concern.
Human E-value
3.97e-06
Gut microbiome similarity
0.8% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
N
DEG identity (%)
26.562 Higher values support similarity to known essential genes.

Structure confidence

ColabFold pLDDT
96.76 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.939
Structure A0A377TPP8
Pocket Pocket 1
Druggability (FPocket) 0.872
Structure A0A377TPP8
Pocket Pocket 1
ColabFold model
P2Rank 0.948 · Pocket 1
FPocket 0.836 · Pocket 1
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 39 / 4744 genomes with a hit
Prevalence 0.8%

Metabolic context

Reactions catalyzed, pathway membership, and centrality in the genome-scale metabolic network.

This protein is not associated with the imported metabolic network for this genome.

Browse the genome's metabolic network

Imported from KpATCC43816.sbml · 2026-07-09

Sequence

Primary amino-acid sequence viewer.

MRLNIAPAPWPGAPVVVLSAGLGGGGGYWLAQRAALEEQYQLVSYDHNGTGENAGPLPADYSLATMAGELFSALQAAGIARFALVGHALGALIGLQLALDRPEAVSALALVNGWLSLSPHTRRCFQVRERLLHAGGAQAWVEAQPLFLYPAEWMAARLPRLEAEDALAISHFQGKENLLKRLQALKQADFSRRASAIACPTLIISAADDLLVPASCSRVLQTAIPGSQLVEMPRGGHACNVTDADTFNTILRDGLSAMLPVARETR

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 4 GO

Subcellular localization

Localization
Unknown

Enzyme Commission (EC)

1

Gene Ontology (GO)

4
  • GO:0006212 The chemical reactions and pathways resulting in the breakdown of uracil, 2,4-dioxopyrimidine, one of the pyrimidine bases occurring in RNA, but not in DNA.
  • GO:0016811 Catalysis of the hydrolysis of any non-peptide carbon-nitrogen bond in a linear amide.
  • GO:0016746 Catalysis of the transfer of an acyl group from one compound (donor) to another (acceptor).
  • GO:0019740 A series of processes that forms an integrated mechanism by which a cell or an organism detects the depletion of primary nitrogen source, usually ammonia, and then activates genes to scavenge the last traces of the primary nitrogen source and to transport and metabolize alternative nitrogen sources. The utilization process begins when the cell or organism detects nitrogen levels, includes the activation of genes whose products detect, transport or metabolize nitrogen-containing substances, and ends when nitrogen is incorporated into the cell or organism's metabolism.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

19 records
Show feature table
Start End DB Term Name
14 119 Pfam PF00561 alpha/beta hydrolase fold
14 119 InterPro IPR000073 Alpha/beta hydrolase fold-1
1 258 Gene3D G3DSA:3.40.50.1820 alpha/beta hydrolase
1 258 InterPro IPR029058 Alpha/Beta hydrolase fold
1 257 NCBIfam TIGR03611 pyrimidine utilization protein D
1 257 InterPro IPR019913 Pyrimidine utilisation protein RutD
98 111 PRINTS PR00111 Alpha/beta hydrolase fold signature
98 111 InterPro IPR000073 Alpha/beta hydrolase fold-1
84 97 PRINTS PR00111 Alpha/beta hydrolase fold signature
84 97 InterPro IPR000073 Alpha/beta hydrolase fold-1
39 54 PRINTS PR00111 Alpha/beta hydrolase fold signature
39 54 InterPro IPR000073 Alpha/beta hydrolase fold-1
201 215 PRINTS PR00111 Alpha/beta hydrolase fold signature
201 215 InterPro IPR000073 Alpha/beta hydrolase fold-1
9 253 SUPERFAMILY SSF53474 alpha/beta-Hydrolases
9 253 InterPro IPR029058 Alpha/Beta hydrolase fold
13 255 PANTHER PTHR43433 HYDROLASE, ALPHA/BETA FOLD FAMILY PROTEIN
1 258 Hamap MF_00832 Putative carbamate hydrolase RutD [rutD].
1 258 InterPro IPR019913 Pyrimidine utilisation protein RutD

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.939
Likely same site as FPocket 1 2.5 Å 22 shared residues 96% of smaller site
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.032
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.009
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #1
0.872
Likely same site as P2Rank 1 2.5 Å 22 shared residues 96% of smaller site
Show in viewer
Surrounding area
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A377TPP8
AlphaFold DB full sequence Viewing
ColabFold VK055_1442
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

55 records
Chemistry signal

Structural ligand evidence is available for this target.

Direct evidence 0 same-protein records
Transferred evidence 5 records from similar proteins
Structural ligands 5 0 loaded crystals
Measured bioactivity 0 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
MLA PDB via homolog 104.1 Da · LogP -0.45 · TPSA 74.6 Open detail RCSB PDB
PCS PDB via homolog Detail RCSB PDB
PHK PDB via homolog Detail RCSB PDB
PMS PDB via homolog Detail RCSB PDB
SHF PDB via homolog Detail RCSB PDB

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
MLA RCSB PDB O07015 104.1 Da LogP -0.45 TPSA 74.6 ✓ Ro5 ✓ Clean C(C(=O)O)C(=O)O
PCS RCSB PDB P96084 197.7 Da LogP 1.36 TPSA 43.1 ✓ Ro5 ✓ Clean c1ccc(cc1)C[C@@H](C(=O)CCl)N
PHK RCSB PDB P96084 199.7 Da LogP 1.16 TPSA 46.2 ✓ Ro5 ✓ Clean c1ccc(cc1)C[C@@H]([C@H](CCl)O)N
PMS RCSB PDB O07015 172.2 Da LogP 1.07 TPSA 54.4 ✓ Ro5 ✓ Clean c1ccc(cc1)CS(=O)(=O)O
SHF RCSB PDB Q13KT2 116.1 Da LogP 0.44 TPSA 54.4 ✓ Ro5 ✓ Clean CC(=O)CCC(=O)O

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.